Latest news from GlaxoSmithKline Consumer Healthcare on News en-us Copyright 2024 News 115 31 / /images/newswise-logo-rss.gif /articles/alli-proven-to-reduce-visceral-fat-a-dangerous-fat-linked-to-many-life-threatening-diseases3/?sc=rsin /articles/alli-proven-to-reduce-visceral-fat-a-dangerous-fat-linked-to-many-life-threatening-diseases3/?sc=rsin Wed, 27 Jan 2010 19:00:00 EST New studies show that overweight and obese people using alli(r) (orlistat 60 mg) with a reduced calorie, lower-fat diet can significantly reduce weight, visceral fat, and waist circumference and therefore may reduce their risk of type 2 diabetes, hypertension, heart disease and stroke. The studies were presented at the 1st International Congress on Abdominal Obesity in Hong Kong earlier today. GlaxoSmithKline Consumer Healthcare /articles/eight-in-10-americans-say-they-re-in-control-of-their-eating-habits-but-growing-obesity-crisis-tells-another-story/?sc=rsin /articles/eight-in-10-americans-say-they-re-in-control-of-their-eating-habits-but-growing-obesity-crisis-tells-another-story/?sc=rsin Thu, 14 Jan 2010 00:00:00 EST Are Americans in denial about their eating habits? Today, two out of three Americans are overweight or obese, and by 2030 that figure will balloon to nearly nine out of 10. Yet in a new national survey, three-quarters of respondents (74%) said they have a healthy personal relationship with food--revealing a clear disconnect between how we think and how we act when it comes to eating. GlaxoSmithKline Consumer Healthcare, the maker of alli(r), sponsored the survey to better understand America's unhealthy relationship with food and develop solutions to help people change the way they eat. GlaxoSmithKline Consumer Healthcare